Vaccine for kids by September-October this year

Director of Pune’s Indian Council of Medical Research- NIV, said that the vaccine for coronavirus might be available for use for children since September or October this year.

Dr. Abraham said, in an interview to an OTT platform, that the phase 2 and phase 3 trials of Covaxin are ...

NIVEA ACCELERATOR PROGRAM (NX) FINDS ABLE LAUNCHPAD IN KOREAN STARTUPS

• Jacek Brozda, head of Ventures and New Business at Beiersdorf Korea, established the NIVEA Accelerator (NX) together with general manager Endrik Hasemann in June 2019.
• NX is Beiersdorf's first global beauty start-up accelerator program the goal of which is to induct selecte...

YET ANOTHER VIRUS FROM CHINA DUBBED CAT QUE VIRUS CAUSING ANXIOUS MOMENTS

• Even as the world is still battling with the COVID-19 pandemic, ICMR scientists have discovered yet another virus from China, the 'Cat Que Virus,' which has all the power to fatally spread diseases across India.
• Even as the world is still grappling with the COVID-19 pan...

BHARAT BIOTECH GETS DCGI APPROVAL TO CONDUCT COVAXIN TEST THROUGH SKIN

Highlights

• According to the reports, the approval from the DCGI is subject to two conditions

• It is stated that if these clinical trials are successful, the vaccine will be available at a cheaper cost

• Union Minister Dr Harsh Vardhan said if everyt...

COVID-19 VACCINE: BHARAT BIOTECH'S COVAXIN SAFE, PHASE II TRIALS TO START IN SEPTEMBER

Highlights

• Total 375 volunteers across 12 sites in India have been given two shots of this COVID-19 vaccine

• As per the reports, no adverse effects were observed at any of the site and the phase 2 trails will start in the month of September

• COVAXI...

COVID-19 VACCINE: HUMAN TRIALS OF COVAXIN BEGIN TODAY AT AIIMS DELHI

Highlights

• People ageing between 18 and 55 and with no comorbidities are eligible to volunteer for the clinical trials of COVAXIN

• COVAXIN developed by Hyderabad-based Bharat Biotech along with the ICMR and the NIV were the first to receive an approval from the DC...

COVAXIN: INDIA’S FIRST COVID-19 VACCINE TO BE TESTED ON 375 PEOPLE IN PHASE I

COVAXIN, the first indigenous COVID-19 vaccine from India is all set to start its human trials from next week. Bharat Biotech, a Hyderabad-based company in association with ICMR and NIV, Pune developed a COVID-19 vaccine that got approval from the DCGI to conduct human trials in the last week. As...

ICMR-BHARAT BIOTECH TO LAUNCH ‘COVAXIN’ BY AUGUST 15

The people of India are hopeful since a company named Bharat Biotech International Limited (BBIL) from Hyderabad is association with the Indian Council of Medical Research (ICMR) got approval from the Drug Controller General of India (DCGI) to conduct Phase I, II Human clinical trials for the COV...